This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1979 Jun 21;300(25):1417-9.

doi: 10.1056/NEJM197906213002505.

Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade

J A Lopez-Ovejero, S D Saal, W A D'Angelo, J S Cheigh, K H Stenzel, J H Laragh

PMID: 220537
DOI: 10.1056/NEJM197906213002505

Case Reports

Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade

J A Lopez-Ovejero et al. N Engl J Med. 1979.

. 1979 Jun 21;300(25):1417-9.

doi: 10.1056/NEJM197906213002505.

Authors

J A Lopez-Ovejero, S D Saal, W A D'Angelo, J S Cheigh, K H Stenzel, J H Laragh

PMID: 220537
DOI: 10.1056/NEJM197906213002505

No abstract available

PubMed Disclaimer

Similar articles

Failure of captopril to reverse the renal crisis of scleroderma.
Brown EA, Macgregor GA, Maini RN. Brown EA, et al. Ann Rheum Dis. 1983 Feb;42(1):52-3. doi: 10.1136/ard.42.1.52. Ann Rheum Dis. 1983. PMID: 6338841 Free PMC article.
[Scleroderma renal crisis (SRC): hypertensive, normotensive].
Endo H. Endo H. Nihon Rinsho Meneki Gakkai Kaishi. 2000 Dec;23(6):656-60. Nihon Rinsho Meneki Gakkai Kaishi. 2000. PMID: 11210764 Japanese. No abstract available.
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.
Gavras H, Brunner HR, Turini GA, Kershaw GR, Tifft CP, Cuttelod S, Gavras I, Vukovich RA, McKinstry DN. Gavras H, et al. N Engl J Med. 1978 May 4;298(18):991-5. doi: 10.1056/NEJM197805042981803. N Engl J Med. 1978. PMID: 205788
Special uses for captopril.
Materson BJ. Materson BJ. Am J Kidney Dis. 1987 Jul;10(1 Suppl 1):88-93. Am J Kidney Dis. 1987. PMID: 2886046 Review.
Use of angiotensin-converting-enzyme inhibitors in the management of renal disease.
Asher JP, Murray KM. Asher JP, et al. Clin Pharm. 1991 Jan;10(1):25-31. Clin Pharm. 1991. PMID: 1999085 Review.

See all similar articles

Cited by

Combination therapies for systemic sclerosis.
Denton CP, Black CM. Denton CP, et al. Springer Semin Immunopathol. 2001;23(1-2):109-29. doi: 10.1007/s002810100058. Springer Semin Immunopathol. 2001. PMID: 11455851 Review. No abstract available.
Favourable outcome of scleroderma renal crisis.
Collins DA, Patel S, Eastwood JB, Bourke BE. Collins DA, et al. J R Soc Med. 1996 Jan;89(1):49P-50P. doi: 10.1177/014107689608900114. J R Soc Med. 1996. PMID: 8709086 Free PMC article.
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.
Heel RC, Brogden RN, Speight TM, Avery GS. Heel RC, et al. Drugs. 1980 Dec;20(6):409-52. doi: 10.2165/00003495-198020060-00001. Drugs. 1980. PMID: 7009133 Review.
Angiotensin converting enzyme inhibitors in Raynaud's phenomenon.
Challenor VF. Challenor VF. Drugs. 1994 Dec;48(6):864-7. doi: 10.2165/00003495-199448060-00003. Drugs. 1994. PMID: 7533694 Review.
Complement activation in atypical hemolytic uremic syndrome and scleroderma renal crisis: a critical analysis of pathophysiology.
Zuckerman R, Asif A, Costanzo EJ, Vachharajani T. Zuckerman R, et al. J Bras Nefrol. 2018 Jan-Mar;40(1):77-81. doi: 10.1590/2175-8239-JBN-3807. Epub 2018 May 7. J Bras Nefrol. 2018. PMID: 29796581 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.